Martin‐Lesende 2013.

Methods	Study design: multi‐centre, open‐label, parallel individual randomised controlled trial Duration: 52 weeks Setting: primary care health centres in Spain
Participants	Population: 58 adults recruited from 20 health centres in Bilbao, Spain Baseline characteristics: % Male: 50 RM and 66.7 UC, 57.1 RM and 46.7 UC, % Anxiety and depression: not reported, Baseline meds: not reported, FEV₁: not reported, FVC: not reported, FEV₁/FVC: not reported, Current smokers (n): not reported, GOLD stage: moderate (17.4%), severe (21.7%), and very severe (60.9%), COPD exacerbations last 12 months: not reported, Hospitalisation in past 12 months: not reported Inclusion criteria: home care adult patients, diagnosis of heart failure and/or chronic lung disease 14+ years, history of 2+ hospital admissions in last year with at least 1 admission associated with at least 1 of said conditions for study Exclusion criteria: in residential care, receiving regular monitoring or treatment by specialist or hospitalist services, life expectancy < 6 months due to other illness, known cognitive impairment, not willing to participate
Interventions	Measurements at baseline and at 3, 6, and 12 months Treatment arms PDA device to transmit self‐measured data via Bluetooth wireless to web‐based platform daily Data assessed Monday through Friday during business hours
Outcomes	Primary outcomes: number of hospital admissions Secondary outcomes: length of hospital stay, mortality, use of other healthcare resources (ED visits, home visits, health centres, specialists, telephone calls), number of alerts by telemonitoring system in 5 days leading up to admission
Notes	Funding: Spanish Ministry of Health Other identifier: ISRCTN89041993